Fatty acid synthase (FAS) is the key enzyme of de novo fatty acid synthesis and has been shown to be involved in carcinogenesis of numerous human malignancies, including breast, colorectal, and prostate carcinomas, often associated with a worse prognosis. Although FAS is mainly expressed in the liver, an implication of FAS in hepatocarcinogenesis, has not yet been investigated. FAS expression is stimulated by insulin and glucose, and insulin is also the primary trigger of hepatocarcinogenesis in an endocrine experimental model, which is induced by low-number transplantation of islets of Langerhans into the livers of diabetic rats. We therefore investigated, whether FAS is implicated in hepatocarcinogenesis in this model and in comparison to chemically induced hepatocarcinogenesis after N-nitrosomorpholine (NNM) treatment in diabetic and normoglycemic rats. Preneoplastic clear-cell foci of altered hepatocytes (FAH), harvested after laser-microdissection of kryostat sections, showed an overexpression of FAS messenger RNA in gene expression profiles, done by arrayhybridization, and in quantitative RT-PCR (Light-Cycler). Virtually, all (96-98%) of the subsequently investigated FAH and the glycogenotic hepatocellular adenomas and carcinomas showed an additional strong FAS protein overexpression. In the NNM-model, FAS protein was also overexpressed in the vast majority (87%) of glycogenotic FAH and neoplasms, in particular in the diabetic animals. Also two spontaneous glycogenotic FAH in control animals displayed strong FAS overexpression. Basophilic lesions and neoplasms, which occasionally develop out of the primary clear-cell FAH at later stages of carcinogenesis, however, lost FAS overexpression. In conclusion, FAS overexpression is an early phenonemon in spontaneous, hormonally and chemically induced rat hepatocarcinogenesis, demonstrable in early clear-cell (glycogenotic) FAH and hepatocellular neoplasms. Keywords: fatty acid synthase; glucose; hepatocarcinogenesis; insulin; islet transplantatation; N-nitrosomorpholine After low-number transplantation of islets of Langerhans into the livers of diabetic rats, the liver acini draining the blood from the islet grafts show cellular alterations, the foci of altered hepatocytes (FAH). 1 FAH resemble the glycogen-storing or clear-cell phenotype of preneoplastic foci known from experimental and human hepatocarcinogenesis. 2,3 In the transplantation model, these preneoplastic FAH may develop into hepatocellular adenomas (HCA) and carcinomas (HCC) within 6-24 months after islet transplantation. 4 Previous results indicate that insulin is the primary trigger for the development of FAH and hepatocarcinogenesis in this model. 1,[4][5][6][7] In the beginning of the carcinogenic process, however, these FAH can be regarded as purely adaptative in nature. At this stage, insulin effects manifested in several aspects, that is, an increase in glycogen storage and proliferative activity, lipid accumulation, and altered expression of several insulinrelated proteins, including IGF-I a...